Prevalence and concentrations of drugs in older suspected drugged drivers

References

• Act on Medical and Health Research. 2008. Available at: https://www.etikkom.no/en/library/practical-information/legal-statutes-and-guidelines/the-health-research-act/. (Last accessed: January 26. 2017).
   Google Scholar
• Bocca ML, Marie S, Lelong-Boulouard V, et al. Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects. Psychopharmacology (Berl). 2011;214:699–706.
   PubMed Web of Science ®Google Scholar
• Bogstrand ST, Gjerde H. Which drugs are associated with highest risk for being arrested for driving under the influence? A case–control study. Forensic Sci Int. 2014;240:21–28.
   PubMed Web of Science ®Google Scholar
• Cheung I, McCartt AT, Braitman KA. Exploring the declines in older driver fatal crash involvement. Ann Adv Automot Med. 2008;52:255– 264.
   PubMedGoogle Scholar
• Christophersen AS, Morland J. Frequent detection of benzodiazepines in drugged drivers in Norway. Traffic Inj Prev. 2008;9:98–104.
   PubMed Web of Science ®Google Scholar
• Christophersen AS, Skurtveit S, Grung M, Morland J. Rearrest rates among Norwegian drugged drivers compared with drunken drivers. Drug Alcohol Depend. 2002;66:85–92.
   PubMed Web of Science ®Google Scholar
• Cook LJ, Knight S, Olson LM, Nechodom PJ, Dean JM. Motor vehicle crash characteristics and medical outcomes among older drivers in Utah, 1992–1995. Ann Emerg Med. 2000;35:585–591.
   PubMed Web of Science ®Google Scholar
• Cooper L, Meuleners LB, Duke J, Jancey J, Hildebrand J. Psychotropic medications and crash risk in older drivers: a review of the literature. Asia Pac J Public Health. 2011;23:443–457.
   PubMed Web of Science ®Google Scholar
• Dahl SR, Olsen KM, Strand DH. Determination of gamma-hydroxybutyrate (GHB), beta-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and gamma-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;885–886:37–42.
   PubMed Web of Science ®Google Scholar
• Drummer OH, Gerostamoulos J, Batziris H, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev. 2004;36:239–248.
   PubMed Web of Science ®Google Scholar
• Engeland A, Skurtveit S, Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol. 2007;17:597–602.
   PubMed Web of Science ®Google Scholar
• Evers EA, Tillie DE, van der Veen FM, et al. Effects of a novel method of acute tryptophan depletion on plasma tryptophan and cognitive performance in healthy volunteers. Psychopharmacology (Berl). 2005;178:92–99.
   PubMed Web of Science ®Google Scholar
• Foley DJ, Heimovitz HK, Guralnik JM, Brock DB. Driving life expectancy of persons aged 70 years and older in the United States. Am J Public Health. 2002;92:1284–1289.
   PubMed Web of Science ®Google Scholar
• Gjerde H, Christophersen AS, Normann PT, Morland J. Toxicological investigations of drivers killed in road traffic accidents in Norway during 2006–2008. Forensic Sci Int. 2011;212:102–109.
   PubMed Web of Science ®Google Scholar
• Gjerde H, Christophersen A, Normann PT, Morland J. Associations between substance use among car and van drivers in Norway and fatal injury in road traffic accidents: a case–control study. Transp Res Part F Traffic Psychol Behav. 2013;17:134–145.
   Web of Science ®Google Scholar
• Gjerde H, Normann PT, Christophersen AS, Samuelsen SO, Morland J. Alcohol, psychoactive drugs and fatal road traffic accidents in Norway: a case–control study. Accid Anal Prev. 2011;43:1197–1203.
   PubMed Web of Science ®Google Scholar
• Gjerde H, Normann PT, Pettersen BS, et al. Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. Accid Anal Prev. 2008;40:1765–1772.
   PubMed Web of Science ®Google Scholar
• Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Morland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med. 2008;9:818–822.
   PubMed Web of Science ®Google Scholar
• Hels T, Lyckegaard A, Simonsen KW, Steentoft A, Bernhoft IM. Risk of severe driver injury by driving with psychoactive substances. Accid Anal Prev. 2013;59:346–356.
   PubMed Web of Science ®Google Scholar
• Hoiseth G, Andas H, Bachs L, Morland J. Impairment due to amphetamines and benzodiazepines, alone and in combination. Drug Alcohol Depend. 2014;145:174–179.
   PubMed Web of Science ®Google Scholar
• Hoiseth G, Kristiansen KM, Kvande K, Tanum L, Lorentzen B, Refsum H. Benzodiazepines in geriatric psychiatry: what doctors report and what patients actually use. Drugs Aging. 2013;30:113–118.
   PubMed Web of Science ®Google Scholar
• Hoiseth G, Middelkoop G, Morland J, Gjerde H. Has previous abuse of Flunitrazepam been replaced by Clonazepam? Eur Addict Res. 2015;21:217–221.
   PubMed Web of Science ®Google Scholar
• Kristoffersen L, Smith-Kielland A. An automated alcohol dehydrogenase method for ethanol quantification in urine and whole blood. J Anal Toxicol. 2005;29:387–389.
   PubMed Web of Science ®Google Scholar
• Kristoffersen L, Stormyhr LE, Smith-Kielland A. Headspace gas chromatographic determination of ethanol: the use of factorial design to study effects of blood storage and headspace conditions on ethanol stability and acetaldehyde formation in whole blood and plasma. Forensic Sci Int. 2006;161:151– 157.
   PubMed Web of Science ®Google Scholar
• Leufkens TR, Vermeeren A. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo. J Clin Psychopharmacol. 2009;29:432–438.
   PubMed Web of Science ®Google Scholar
• Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology. 1994;5:591–598.
   PubMed Web of Science ®Google Scholar
• Meuleners LB, Duke J, Lee AH, Palamara P, Hildebrand J, Ng JQ. Psychoactive medications and crash involvement requiring hospitalization for older drivers: a population-based study. J Am Geriatr Soc. 2011;59:1575–1580.
   PubMed Web of Science ®Google Scholar
• Norwegian Research Ethics Act. 2006. Available at: http://app.uio.no/ub/ujur/oversatte-lover/data/lov-20060630-056-eng.pdf. (Last accessed: January 26, 2017).
   Google Scholar
• Norwegian Institute of Public Health. Rusmiddelstatistikk [Drug statistics]. Oslo: Division of Forensic Sciences; 2015.
   Google Scholar
• Oiestad EL, Johansen U, Oiestad AM, Christophersen AS. Drug screening of whole blood by ultra-performance liquid chromatography–tandem mass spectrometry. J Anal Toxicol. 2011;35:280–293.
   PubMed Web of Science ®Google Scholar
• Orriols L, Wilchesky M, Lagarde E, Suissa S. Prescription of antidepressants and the risk of road traffic crash in the elderly: a case–crossover study. Br J Clin Pharmacol. 2013;76:810–815.
   PubMed Web of Science ®Google Scholar
• Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol. 1992;136:873–883.
   PubMed Web of Science ®Google Scholar
• Vindenes V, Jordbru D, Knapskog AB, et al. Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway. Forensic Sci Int. 2012;219:1–11.
   PubMed Web of Science ®Google Scholar
• Williams AF, Carsten O. Driver age and crash involvement. Am J Public Health. 1989;79:326–327.
   PubMed Web of Science ®Google Scholar
• Zhang J, Fraser S, Lindsay J, Clarke K, Mao Y. Age-specific patterns of factors related to fatal motor vehicle traffic crashes: focus on young and elderly drivers. Public Health. 1998;112:289–295.
   PubMed Web of Science ®Google Scholar